Key Resolution Details

Resolution Type: Special Resolution

Subject: Re-appointment of Mr. Balasaheb Sawant (DIN: 07743507) as Whole Time Director and Key Managerial Personnel of the Company

Term: Three consecutive years from May 26, 2026, to May 25, 2029

Remuneration: Not exceeding ₹8,78,080 per month including Basic Salary, House Rent Allowance, other Perquisites and allowances, Bonus, performance incentives, Commission and other additional perquisites

Remuneration Terms and Conditions

The resolution specifies that in case the company has no profits or inadequate profits in any financial year during the tenure, the company shall pay remuneration subject to approval of the Central Government wherever required, and subject to provisions of Sections 197, 198 and 203 read with Schedule V of the Companies Act 2013. The computation excludes:

  • Contributions to provident fund, superannuation fund or annuity fund to the extent not taxable under Income Tax Act, 1961
  • Gratuity payable at rate not exceeding half a month's salary for each completed year of service
  • Encashment of leave at end of tenure

Mr. Sawant shall also be entitled to reimbursement of all out-of-pocket expenses incurred for company business.

Voting Process and Timeline

Cut-off Date: July 17, 2026 (for determining eligible voters)

Remote E-voting Period: July 23, 2026 (9:00 AM IST) to August 21, 2026 (5:00 PM IST)

Result Declaration: On or before August 22, 2026

Scrutinizer: CS Sanam Umbargikar (FCS 11777), Partner of M/s. DSM & Associates, Company Secretaries

E-voting Service Provider: National Securities Depository Limited (NSDL)

The notice is being sent only through electronic mode to members whose email addresses are registered with the Company/Registrar and Transfer Agent/Depositories.

Director Background Information

Mr. Balasaheb Sawant (DIN: 07743507)

  • Age: 62 years (born June 1, 1964)
  • Qualification: Bachelor's and Master's degree in Science from Mudoji College, Shivaji University, Kolhapur
  • Experience: Over 29 years in API Production Planning, Material Management & process enhancement
  • Previous associations: USV Limited (Plant Manager), Encure Pharmaceuticals Limited (Senior General Manager Production), Arch Pharmalabs Limited, Mylan Laboratories Limited, Enaltec Labs Private Limited (Head Operations)
  • Current directorships: Only Supriya Lifescience Limited
  • Shareholding: Holds no shares in the company
  • Board meeting attendance: 4 meetings during 2025-26
  • First appointment: February 24, 2017

Authorization and Compliance

The Board has authorized Dr. Satish Wagh (Chairman and Executive Director), Dr. Saloni Wagh (Managing Director), Mr. Krishna Raghunathan (Chief Financial Officer), and/or Ms. Prachi Sathe (Company Secretary) to execute all necessary documents and arrangements for this appointment.

Document Availability

The notice is available on the company's website (www.supriyalifescience.com), NSDL's website (www.evoting.nsdl.com), and stock exchange websites (www.bseindia.com and www.nseindia.com).